Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics AntigenID

Cancer Genetics has launched a neoantigen discovery service it calls AntigenID designed to identify neoantigens and neoantigen signatures that can accelerate immuno-oncology drug discovery, predict patient-specific immune therapy response, and help create personalized immuno-vaccines. AntigenID incorporates genomic and transcriptomic profiles, HLA typing, and bioinformatic strategies, the company said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.